BioCentury
ARTICLE | Top Story

Alnylam up on Novartis deal

September 8, 2005 1:18 AM UTC

Alnylam (ALNY) was up $4.19 (44%) to $13.75 on 6.4 million shares on Wednesday after announcing that Novartis (NVS; SWX:NOVN) will acquire a 19.9% stake in the company as part of a three-year deal to ...